Cannabis based drug is licensed for spasticity in patients with MS

BMJ. 2010 Jun 22:340:c3363. doi: 10.1136/bmj.c3363.
No abstract available

Publication types

  • News

MeSH terms

  • Cannabidiol
  • Cannabinoids / therapeutic use*
  • Cannabis*
  • Dronabinol
  • Drug Approval
  • Drug Combinations
  • Humans
  • Multiple Sclerosis / complications*
  • Muscle Spasticity / drug therapy*
  • Parasympatholytics / therapeutic use*
  • Plant Extracts / therapeutic use*

Substances

  • Cannabinoids
  • Drug Combinations
  • Parasympatholytics
  • Plant Extracts
  • Cannabidiol
  • Dronabinol
  • nabiximols